Podophyllotoxin: Critical Review, Commercial Development
VerifiedAdded on 2022/08/25
|5
|843
|35
Report
AI Summary
This report provides a critical review of Podophyllotoxin, a lignan toxin derived from plants, exploring its history, biodiversity, and toxicity. The review examines the synthesis, biosynthesis, and medical applications of Podophyllotoxin, highlighting its use in traditional medicine and its derivatives, such as etoposide and teniposide, used in cancer treatment. It addresses the mode of action, including the inhibition of TOP2 and microtubule hindrance. The report also discusses the toxicity associated with Podophyllotoxin and compares it with other drugs in the market, such as TrichloroAceticAcid (TCA), Aldara cream, Sinecatechis, and Thuja, used for treating genital warts. The conclusion evaluates the suitability of Podophyllotoxin for commercial development, considering factors like cost of synthesis, biodiversity, and the presence of alternative treatments. The report uses Vancouver style of referencing.
1 out of 5